Optimus Holding Ltd. is a Swiss Group based in Geneva, founded by Etienne Jornod together with long-standing Swiss entrepreneurs and Abdi Ibrahim (28.5%), a pharmaceutical company operating in 12 countries and exporting to 60 countries worldwide, as a strategic partner. Optimus Holding is fully committed to the sustainable growth of OM Pharma and to invest a triple digit million amount to create a highly attractive global biotechnology company focused on improving the lives of patients with respiratory and inflammatory diseases. They also have a strong desire to further strengthen the Swiss footprint of OM Pharma by investing into people, increasing the employee base, stepping-up manufacturing and deepen research and development activities in Switzerland. OM Pharma is a Geneva-based Biotech company and a leader in the prevention of recurrent respiratory and urinary tract infections. It is also active in the treatment of vascular diseases. It operates worldwide through a strong network of international partners and continues to invest into R&D to develop immunotherapeutic products addressing acute and chronic immunological disorders resulting from infections and inflammation.